FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
作者： Jean-Luc Raoul , Laurence Choné , Eric Francois , Pascal Artru , James J. Biagi
关键词:
摘要: … Adverse events of grade 3 or 4 occurred in 75.9% of the patients in the modified-FOLFIRINOX group … On the basis of these results, we initiated a phase 3 trial to explore the efficacy of …
umontpellier.fr
sci-hub.se 参考文章(0)